Skip to main content
OpenTrials

Clinical trial condition

Autoimmune Lymphoproliferative Syndrome

Explore clinical trials studying Autoimmune Lymphoproliferative Syndrome. Study availability and eligibility vary by location and protocol.

11 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Autoimmune Lymphoproliferative Syndrome trial results

Recruiting

Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients

NCT06730126

Conditions
Autoimmune Diseases, Autoimmune Lymphoproliferative Syndrome, Autoimmune Lymphoproliferative Syndrome, Type IA, +9 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Enrolling by Invitation

Comparative Autoantibody and Immunologic Cell Marker Study

NCT02422875

Conditions
Acquired Immunodeficiency Syndrome, Arthritis, Arthritis, Juvenile, +85 more
Locations
  • Emory University Hospital Atlanta, Georgia, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Grady Health System Atlanta, Georgia, United States
View Trial Details

Related conditions